Примери за използване на Progress to severe на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
In isolated cases, these reactions may progress to severe anaphylaxis.
Falciparum can progress to severe illness which often leads to death.
Hypersensitivity(allergic) reactions can occur rarely with NovoEight andmay in some cases progress to severe allergic reactions.
Falciparum may progress to severe illness which can then lead to death.
In the most advanced cases where many adult worms have built up in the heart without treatment,signs progress to severe weight loss, fainting, coughing up blood and, finally, congestive heart failure.
For example, up to two-thirds of all dengue virus infections result in no symptoms, while the remaining one-third go on to develop dengue fever and even fewer progress to severe dengue.
Falciparum malaria can progress to severe illness, often leading to death.- VNS.
Hypersensitivity or allergic reactions(which may include angioedema, burning and stinging at the infusion site, chills, flushing, generalised urticaria, headache, hives, hypotension, lethargy, nausea, restlessness, tachycardia, tightness of the chest, tingling, vomiting, wheezing) have been observed rarely andmay in some cases progress to severe anaphylaxis(including shock).
In particular the skin related reactions may occur commonly, whereas a progress to severe anaphylaxis(including shock) is considered to be rare.
Hypersensitivity or allergic reactions(which may include angioedema, burning and stinging at the injection site, chills, flushing, generalized urticaria, headache, hives, hypotension, lethargy, nausea, restlessness, tachycardia, tightness of the chest, tingling, vomiting, wheezing)are possible and may progress to severe anaphylaxis(including shock)(see section 4.4).
In the most serious cases, allergic reactions may progress to severe anaphylactic reactions even when the patient has shown no hypersensitivity to previous administrations(see section 4.4).
Hypersensitivity or allergic reactions(which may include angioedema, burning and stinging at the infusion site, chills, flushing, generalised urticaria, headache, hives, hypotension, lethargy, nausea, restlessness, tachycardia, tightness of the chest, tingling, vomiting, wheezing) have been observed rarely andmay in some cases progress to severe anaphylaxis(including shock).
Hypersensitivity or allergic reactions(which may include angioedema, burning and stinging at the injection site, chills, flushing, generalised urticaria, headache, hives, hypotension, lethargy, nausea, restlessness, tachycardia, tightness of the chest, tingling, vomiting, wheezing) have been observed rarely andmay in some cases progress to severe anaphylaxis(including shock).
Hypersensitivity or allergic reactions(which may include angioedema, burning and stinging at the injection site, chills, flushing, generalized urticaria, headache, hives, hypotension, lethargy, nausea, restlessness, tachycardia, tightness of the chest, tingling, vomiting, wheezing) have been observed andmay in some cases progress to severe anaphylaxis(including shock).
Hypersensitivity or allergic reactions(which may include angioedema, burning and stinging at the infusion site, chills, flushing, generalised urticaria, headache, hives, hypotension, lethargy, nausea, restlessness, tachycardia, tightness of the chest, tingling, vomiting, wheezing) have been observed rarely andmay in some cases progress to severe anaphylaxis(including shock).
Hypersensitivity or allergic reactions(which may include angioedema, burning and stinging at the infusion site, chills, flushing, generalised urticaria, headache, hives, hypotension, lethargy, nausea, restlessness, tachycardia, tightness of the chest, tingling, vomiting, wheezing) have been observed andmay in some cases progress to severe anaphylaxis(including shock).
Hypersensitivity or allergic reactions(which may include angioedema, burning and stinging at the infusion site, chills, flushing, generalised urticaria, headache, hives, hypotension, lethargy, nausea, restlessness, tachycardia, tightness of the chest, tingling, vomiting, wheezing) have been observed rarely andmay in some cases progress to severe anaphylaxis(including shock).
Hypersensitivity or allergic reactions(which may include swelling of the face, rash, hives, tightness of the chest and difficulty breathing, burning and stinging at the infusion site, chills, flushing, generalised urticaria, headache, hypotension, lethargy, nausea, restlessness, tachycardia) have been observed rarely andmay in some cases progress to severe anaphylaxis(including shock).
Hypersensitivity or allergic reactions(which may include angioedema, burning and stinging at the infusion site, chills, flushing, generalised urticaria, headache, hives, hypotension, lethargy, nausea, restlessness, tachycardia, tightness of the chest, tingling, vomiting, wheezing) have been observed infrequently for ReFacto, andmay in some cases progress to severe anaphylaxis including shock(see section 4.4).
Hypersensitivity or allergic reactions(which may include angioedema, burning and stinging at the infusion site, chills, flushing, generalised urticaria, headache, hives, hypotension, lethargy, nausea, restlessness, tachycardia, tightness of the chest, tingling, vomiting, wheezing) have been observed with recombinant factor VIII products andmay in some cases progress to severe anaphylaxis(including shock).
Hypersensitivity or allergic reactions(which may include angioedema, burning and stinging at the infusion site, chills, flushing, generalised urticaria, headache, hives, hypotension, lethargy, nausea, restlessness, tachycardia, tightness of the chest, tingling, vomiting, wheezing) have been observed rarely with recombinant factor IX products andmay in some cases progress to severe anaphylaxis(including shock).
Hypersensitivity or allergic reactions(which may include angioedema, burning and stinging at the injection site, chills, flushing, generalised urticaria, headache, hives, hypotension, lethargy, nausea, restlessness, tachycardia, tightness of the chest, tingling, vomiting, wheezing) have been observed rarely with the use of factor VIII products andmay in some cases progress to severe anaphylaxis(including shock).
Hypersensitivity or allergic reactions(which may include angiooedema, burning and stinging at the infusion site, chills, flushing, headache, hives, hypotension, lethargy, nausea, rash, restlessness, tachycardia, tightness of the chest, tingling, urticaria, including generalised urticaria, vomiting, wheezing) have rarely been observed with FVIII preparations andmay in some cases progress to severe anaphylaxis(including shock).
Hypersensitivity or allergic reactions(which may include angioedema, burning and stinging at the infusion site, chills, flushing, generalised urticaria, headache, hives, hypotension, lethargy, nausea, restlessness, tachycardia, tightness of the chest(including chest pain and chest discomfort), back pain, tingling, vomiting, wheezing) have been observed, andmay in some cases progress to severe anaphylaxis(including shock).
In isolated cases, these reactions have progressed to severe anaphylaxis.
In some cases, these reactions have progressed to severe anaphylaxis.
For moderate rash that progresses to severe(≥ 50% body surface area), permanently discontinue INCIVO(see below).
In some cases, these reactions have progressed to severe anaphylaxis, and they have occurred in close temporal association with development of factor IX inhibitors(see also 4.4).
In some cases, these reactions have progressed to severe anaphylaxis, and they have occurred in close temporal association with development of factor IX inhibitors(see also section 4.4).
In some cases, these reactions have progressed to severe anaphylaxis, and they have occurred in close temporal association with development of factor IX inhibitors(see also 4.4).